...
首页> 外文期刊>Angewandte Chemie >Paenilamicin: Structure and Biosynthesis of a Hybrid Nonribosomal Peptide/Polyketide Antibiotic from the Bee Pathogen Paenibacillus larvae
【24h】

Paenilamicin: Structure and Biosynthesis of a Hybrid Nonribosomal Peptide/Polyketide Antibiotic from the Bee Pathogen Paenibacillus larvae

机译:帕尼米星:蜜蜂病原体幼芽孢杆菌幼虫的混合非核糖体肽/聚酮类抗生素的结构和生物合成。

获取原文
获取原文并翻译 | 示例
           

摘要

The spore-forming bacterium Paenibacillus larvae is the causative agent of American Foulbrood (AFB), a fatal disease of honey bees that occurs worldwide. Previously, we identified a complex hybrid nonribosomal peptide/polyketide synthesis (NRPS/PKS) gene cluster in the genome of P. larvae. Herein, we present the isolation and structure elucidation of the antibacterial and antifungal products of this gene cluster, termed paenilamicins. The unique structures of the paenilami-cins give deep insight into the underlying complex hybrid NRPS/PKS biosynthetic machinery. Bee larval co-infection assays reveal that the paenilamicins are employed by P. larvae in fighting ecological niche competitors and are not directly involved in killing the bee larvae. Their antibacterial and antifungal activities qualify the paenilamicins as attractive candidates for drug development.
机译:形成孢子的幼虫Paenibacillus幼虫是美国Foulbrood(AFB)的病原体,AFB是全球范围内发生的致命性蜜蜂疾病。以前,我们在幼虫的基因组中鉴定了一个复杂的杂种非核糖体肽/聚酮化合物合成(NRPS / PKS)基因簇。在本文中,我们介绍了该基因簇的抗菌和抗真菌产品,称为paenilamicins的分离和结构解析。 paenilami-cins的独特结构使人们深入了解了潜在的复杂杂化NRPS / PKS生物合成机制。蜜蜂幼虫共感染试验表明,青霉菌素被P.幼虫用于对抗生态位竞争者,并且不直接参与杀死蜜蜂的幼虫。他们的抗菌和抗真菌活性使培拉米星成为药物开发的有吸引力的候选药物。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号